Results filed 22 October 2026 · Market cap ₹801 crore · PE 32.7
GrowthGuidance maintainedTranscript read
Revenue
+49.7%
on a year ago
EBITDA
+319.4%
on a year ago
Profit to shareholders
+1220.8%
on a year ago
EBITDA margin
10.5%
+0.4 pts on last quarter
Fairchem Organics reported Q2 FY27 revenue of Rs. 167 crore, reflecting a 49.7% YoY increase, while EBITDA margins recovered to 10.51% due to reduced Chinese dumping and higher product realizations. The company continues to operate at a modest 60% to 65% capacity utilization, with expectations to increase utilization by 5% quarterly as duty cuts on crude soybean oil enhance raw material availability. High shipping freight rates and weak European demand are delaying the company's export expansion into the US and European cosmetics markets.
Source: Fairchem Organics Limited’s filing to NSE, 22 October 2026. Operating profit is revenue less every expense except interest, so it leaves out other income and exceptional items. n.m.: not meaningful, because the earlier figure was zero or negative, or the latest one is a loss.
What stood out
Sharp margin rebound from a low base driven by lower Chinese dumping and higher product realizationsSourceEBITDA margin expanded 674 bps YoY from 3.77% to 10.51% as realization rose from Rs. 106/kg in Q2 FY26 to Rs. 135/kg in Q2 FY27 (Transcript p. 5, Presentation p. 16).
Related-party land acquisition of Rs. 12 crore from promoterSourceCFO Bhavesh Shah noted: 'This land was already in use for our current operations... as well as our workers’ colony... And we thought of buying it from our promoter' for Rs. 12 crores (Transcript p. 8).
Working capital strain with trade receivables crossing Rs. 100 croreSourceTrade receivables rose to Rs. 1,002 Mn in H1 FY27 from Rs. 681 Mn in FY26 (Presentation p. 19), while CFO stated working capital cycle is 90 to 100 days (Transcript p. 9).
Guidance
Metric
Guidance
Period
Capacity utilization growthSourceNahoosh Jariwala: 'every quarter, we expect 5% capacity improvement' (Transcript p. 13).
5% improvement per quarter towards 85%-90%
Quarterly going forward
Quarterly revenue growthSourceNahoosh Jariwala: 'we will try to achieve 5% to 10% growth every quarter' (Transcript p. 12).
5% to 10% growth every quarter
Quarterly
EBITDA Margin aspirationSourceNahoosh Jariwala: 'we should be able to maintain this margin... I would love to see 15%-18%' (Transcript p. 11).
Aiming to maintain current ~10.5% levels and aspire for 15% to 18% as utilization rises
Medium term
Tailwinds
Relief in raw material duty structure improves domestic feed supplySourceImport duty reduction on Crude Soybean Oil from 16.5% to 11% improves oil availability from domestic refiners and softens input prices (Transcript p. 3, 4).
Reduced Chinese dumping supports domestic realizationSourceReduction in Chinese export incentives and rupee depreciation reduced Chinese dumping of dimer acid in India, improving sales realizations to Rs. 135/kg (Transcript p. 5, 8).
Operational cost optimization initiatives completedSourceEnergy savings achieved through an in-depth energy audit and substitution of imported catalyst with domestic catalyst (Presentation p. 21, Transcript p. 11).
Headwinds
High freight costs stalling US export ramp-upSourceSpadework complete, but high container shipping freight costs from India to the US prevent commencement of exports (Transcript p. 6).
Sluggish demand in European cosmetics marketSourceEuropean market slowdown and geopolitical issues are dampening Isostearic Acid adoption in cosmetics in the near term (Transcript p. 9, 13).
Underutilized manufacturing capacitySourcePlant operates at only 60% to 65% utilization due to past raw material availability constraints (Transcript p. 5, 12).
New businesses and products
new product · Plant erected but undergoing modifications based on R&D inputs; commissioning expected in Q3 FY27 post-Diwali
New Fatty Acid derivative product via novel technology
Expected benefit
Addresses a large market with import substitution and export potential
Risks
Hiccups expected during initial commissioning due to novel process and technology
Timeline
Q3 FY27 (October-December quarter)
Investment
Small capacity plant already put up; larger capex planned if product succeeds
SourceNahoosh Jariwala: 'we have put up a small capacity plant and which we expect to commence in October-December quarter. After Diwali, we expect it to start... it's a novel technology, novel process, and so it is going to take its own time' (Transcript p. 7, 13).
SourceNahoosh Jariwala confirmed: 'Yes, it has been commercialized' (Transcript p. 7, Presentation p. 21).
new geography · Spadework and customer approvals completed, but US shipments delayed by high freight rates and European sales slowed by market conditions
Global export expansion for Isostearic Acid and prime products
Expected benefit
Targeting to raise export share initially to 25% and eventually to 50% of total sales
Risks
High shipping freight rates to US and macroeconomic/geopolitical slowdown in Europe
Timeline
When freight rates and European market stabilize
SourcePresentation p. 21 and Nahoosh Jariwala: 'we have done all the spadework for our US exports because of the too high freight cost to US from India, things are not moving as expected' (Transcript p. 6).
Things to check
Profit grew far faster than operating profit: other income, tax or one-offs did some of the work
Year-ago margin under 5%: growth from a low base
Related-party asset purchase of Rs. 12 crore from promoterSourceManagement confirmed purchasing land worth Rs. 12 crores from the promoter that was previously used for operations and a workers' colony (Transcript p. 8).
Sharp increase in trade receivables relative to revenueSourceTrade receivables rose 47% from Rs. 681 Mn in FY26 to Rs. 1,002 Mn in H1 FY27, increasing working capital requirements (Presentation p. 19).
How the call went
Management answered operational and volume-related queries clearly, acknowledging logistical and export market headwinds, but deflected details on feed composition and provided little detail on the new product's chemical composition.
Specific or vague
Provided clear metrics on capacity utilization (60-65%), realizations (Rs. 135/kg), and working capital days (90-100), but was non-specific on the exact chemistry of new products and refused to disclose raw material mix.
Candour
Management was forthright about near-term headwinds in Europe, delays in US exports caused by elevated freight, and initial hiccups expected in the new technology plant.
The hard questions
Analysts probed the related-party land transaction, margin sustainability, and Chinese competition; answers were brief and direct on the land transaction, though somewhat evasive regarding the raw material mix.
What analysts pressed on
Sustainability of 14%-18% EBITDA margins following import duty adjustments
Impact of high container freight costs and European demand slowdown on export rollouts
Justification and purpose of the Rs. 12 crore land purchase from the promoter
Timeline to scale capacity utilization from 60%-65% to 85%-90%
Answers that sidestepped
Refused to reveal the proportion of soybean vs other crude oils in their raw material feed: 'It would be good if we don't share our raw material combination' (Transcript p. 11).
Deflected on China's edible oil import duties: 'Oh, to be frank, next time we will check it out' (Transcript p. 5).
Numbers against the story
Management attributed H1 FY27 revenue growth (+41.4% YoY) primarily to higher price realizations resulting from higher raw material costs and reduced Chinese dumping. However, the reported numbers indicate that while EBITDA rose 316.7% YoY in Q2, sequential top-line declined from Rs. 176 crore in Q1 FY27 to Rs. 167 crore in Q2 FY27. Management highlighted strong export potential, but acknowledged in the call that actual export execution in the US and Europe is currently blocked by freight costs and soft demand.
Figures: the company’s results filing with NSE, linked under the table.
Notes written by gemini-3.8-flash from the documents above on 15 November 2026. They summarise what the company said and can contain mistakes: check the source passage before relying on a point. Not investment advice.